Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Management of Sepsis and Septic Shock
Respiratory guidelines--which real world?
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
Risk of Procedural Hemorrhage.
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (131)
More Search Options
Match
Type
Why
Larson, Richard A.
Person
Why?
Arber, Daniel
Person
Why?
Stock, Wendy
Person
Why?
Godley, Lucy
Person
Why?
Odenike, Olatoyosi
Person
Why?
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study.
Academic Article
Why?
Emerging therapies for acute myeloid leukemia.
Academic Article
Why?
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
Academic Article
Why?
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.
Academic Article
Why?
Acute myeloid leukemia with expanded erythropoiesis.
Academic Article
Why?
Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study.
Academic Article
Why?
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
Academic Article
Why?
c-myc and c-myb expression in acute myelogenous leukemia.
Academic Article
Why?
Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia.
Academic Article
Why?
Chromosome pattern in childhood acute nonlymphocytic leukemia (ANLL).
Academic Article
Why?
Per Page
15
25
50
100
Page
of 9
Next
Prev
Search Criteria
Leukemia Acute Myeloid
Filter by Type
All
(866)
People
(131)
Research
(734)
Concepts
(1)
_
Click "Why?" to see why an item matched the search.